CompBrief BY VELARION

Companies Humana

Humana (HUM): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Humana’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$18,757,075CEO James Rechtin · source
Say-on-pay support95.42%Latest vote · source
CEO vs. named peers35th pct.Of 18 peer CEOs
CEO pay ratio226:1To the median employee · source

CEO pay, last three years

  • $15,579,476FY2024
  • $18,757,075FY2025

CEO total pay was $18,757,075 in fiscal 2025, up from $15,579,476 in fiscal 2024.

FY2025: salary $1,348,558 · bonus $0 · stock awards $13,868,141 · option awards $0

Executives and directors

James Rechtin · CEOJapan Mehta · Chief Information OfficerCeleste Mellet · CFOMichelle O'Hara · Chief Human Resources OfficerSanjay Shetty · PresidentSusan Diamond · CFOBrad D. Smith · Former director (through FY2025)David T. Feinberg, M.D · Independent DirectorFrank A. D'Amelio · DirectorGordon Smith · Independent DirectorJohn W. Garratt · Independent DirectorJorge S. Mesquita · Independent DirectorKaren W. Katz · Independent DirectorKurt J. Hilzinger · Chair of the BoardMarcy S. Klevorn · Independent DirectorRaquel C. Bono, M.D · Independent DirectorWayne A. I. Frederick, M.D · Independent Director

Frequently asked questions

Who was the highest-paid executive at Humana in fiscal 2025?
As disclosed, Celeste Mellet (Chief Financial Officer) was the highest-paid executive at Humana in fiscal 2025, with total compensation of $18,922,704.
How does Humana's chief executive pay compare to its disclosed peer group?
As disclosed, James Rechtin's total compensation ranked at the 35th percentile of Humana's disclosed peer group.
What is Humana's CEO-to-median employee pay ratio?
As disclosed, Humana's CEO-to-median employee pay ratio was 226:1.
How did shareholders vote on Humana's executive compensation?
As disclosed, 95.42% of shareholders supported Humana's executive compensation in the latest say-on-pay vote.
How much does Humana spend in total on board compensation for fiscal 2025?
As disclosed, Humana reported total board compensation of $3,950,878 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Celeste Mellet$900,000$6,000,000$10,651,166$0$1,327,603—$43,935$18,922,704
Chief Financial Officer
James Rechtin1,348,558013,868,14103,034,7400505,63618,757,075
President and Chief Executive Officer
Japan Mehta618,7504,300,0003,908,9030732,78704,1239,564,563
Chief Information Officer
Michelle O'Hara715,3852,500,0004,863,1760840,000024,0778,942,638
Chief Human Resources Officer
Sanjay Shetty715,769250,0005,063,0550963,3350163,5207,155,679
President, CenterWell
Susan Diamond961,0750001,225,0000196,8552,382,930
Former Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Celeste Mellet$18,922,704———
James Rechtin18,757,07515,579,476—↑ +3,177,599
Japan Mehta9,564,563———
Michelle O'Hara8,942,638———
Sanjay Shetty7,155,6796,435,2634,581,941↑ +720,416
Susan Diamond2,382,9309,617,5144,730,733↓ −7,234,584

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is designed to attract, retain, focus and motivate leaders to achieve strategic milestones and performance objectives that advance and grow our integrated care-delivery model. We design our executive compensation programs to challenge participants as well as reward them for superior performance for our Company and our stockholders.

CEO STI target (% of salary)200%
CEO LTI target (% of salary)—
Independent consultantFarient Advisors, LLC
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Japan MehtaPSU2025-02-242,6865,372—10,744$1,688,887
Sanjay ShettyPSU2025-03-124,0018,002—16,0041,999,940
Celeste MelletRSU2025-02-24——6,385—1,640,083
Sanjay ShettyPSU2025-02-243,1536,307—12,6141,982,998
Celeste MelletRSU2025-03-01——23,291—6,000,111
Michelle O'Hara—2025-01-01——4,205—1,080,117
Japan MehtaRSU2025-02-24——3,582—920,090
Sanjay ShettyRSU2025-03-01——4,205—1,080,117
James RechtinRSU2025-02-24——19,037—4,889,939
Celeste MelletPSU2025-02-244,7889,577—19,1543,010,972
Michelle O'HaraPSU2025-02-24—6,3073,15312,6141,982,998
Michelle O'HaraEQUITY2025-03-01——7,061—1,800,061
Japan MehtaRSU2025-02-13——5,046—1,299,925
James RechtinPSU2025-03-0114,27828,556—57,1128,978,202

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Japan Mehta$2,220,015$1,688,887$043.2%
Sanjay Shetty1,080,1173,982,938078.7%
Celeste Mellet7,640,1943,010,972028.3%
Michelle O'Hara01,982,9980100.0%
James Rechtin4,889,9398,978,202064.7%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Sanjay ShettyRSU568—$145,482
Susan DiamondRSU863—221,040
Sanjay ShettyOption1,322487.16—
James RechtinRSU1,362—348,849
Sanjay ShettyPSU1,847—473,072
Susan DiamondOption2,270510.24—
Japan MehtaRSU2,388—611,638
Michelle O'HaraRSU2,804—718,189
Sanjay ShettyRSU2,804—718,189
Sanjay ShettyPSU3,404—871,867
Susan DiamondPSU3,528—903,627
Celeste MelletRSU4,257—1,090,345
James RechtinRSU4,366—1,118,264
Sanjay ShettyOption4,382367.21—
Japan MehtaRSU5,046—1,292,432
Susan DiamondPSU5,174—1,325,217
Japan MehtaPSU5,372—1,375,930
Sanjay ShettyRSU5,446—1,394,884
Michelle O'HaraPSU6,307—1,615,412
Sanjay ShettyPSU6,307—1,615,412
Susan DiamondOption6,660367.21—
Michelle O'HaraRSU7,061—1,808,534
Sanjay ShettyPSU8,002—2,049,552
James RechtinPSU8,170—2,092,582
Celeste MelletPSU9,577—2,452,957
James RechtinOption10,515367.21—
Susan DiamondRSU10,893—2,790,024
James RechtinRSU12,692—3,250,802
James RechtinOption19,487458.19—
Celeste MelletRSU23,291—5,965,524
James RechtinPSU28,556—7,314,048
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Kurt J. HilzingerIndependent · Board Chair · Investment$365,000$200,092$0—$44,986$610,078
Karen W. KatzIndependent · Organization & Compensation · Technology · Nominating, Governance & Sustainability (Chair)145,000200,0920—40,486385,578
Wayne A. I. Frederick, M.DIndependent · Organization & Compensation · Technology145,000200,0920—40,414385,506
Marcy S. KlevornIndependent · Nominating, Governance & Sustainability · Technology (Chair)140,000200,0920—42,286382,378
Jorge S. MesquitaIndependent · Investment125,000200,0920—40,992366,084
Frank A. D'Amelio150,000200,0920—2,786352,878
Raquel C. Bono, M.DIndependent · Audit125,000200,0920—27,286352,378
David T. Feinberg, M.DIndependent · Nominating, Governance & Sustainability · Clinical Quality (Chair)140,000200,0920—1,188341,280
John W. GarrattIndependent · Audit · Clinical Quality · Investment (Chair)140,000200,0920—774340,866
Gordon SmithIndependent · Organization & Compensation (Chair) · Technology125,000200,0920—0325,092
Brad D. SmithIndependent · Organization & Compensation · Technology · Not standing for re-election · Departed during FY41,66766,6970—396108,760
James A. RechtinEmployee director000—00

Board fee structure and ownership guideline

Annual cash retainer$125,000
Annual equity retainer$200,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 20,000
Stock ownership guideline5x annual cash retainer

Total cost of the board

ComponentFY2025
Cash retainers and fees$1,641,667
Equity awards (grant-date value)$2,067,617
All other compensation$241,594
Total cost of the board$3,950,878

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Humana as a peer

Companies that benchmark against HUM

17 companies name HUM as a compensation peer

Each company listed discloses HUM in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named HUM in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

HCA HCA Healthcare, Inc.AFL Aflac, Inc.CNC Centene CorporationELV Elevance Health, Inc.CI The Cigna GroupUNH UnitedHealth Group Inc.COR CencoraDVA DaVita Inc.MET MetLife, Inc.CAH Cardinal Health, Inc.CVS CVS Health CorpMOH Molina HealthcareWBA Walgreens Boots Alliance, Inc.ALL Allstate CorporationPGR Progressive CorporationPRU Prudential Financial, Inc. Laboratory Corporation of America Holdings, Inc.MCK McKesson Corp

Peer reciprocity

Of the companies Humana names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

✓ HCA Healthcare, Inc. (HCA)76✓ Aflac, Inc. (AFL)77✓ Centene Corporation (CNC)78✓ Elevance Health, Inc. (ELV)79✓ The Cigna Group (CI)80✓ UnitedHealth Group Inc. (UNH)81✓ Cencora (COR)82— DaVita Inc. (DVA)83 MetLife, Inc. (MET)— Cardinal Health, Inc. (CAH)84 CVS Health Corp (CVS)✓ Molina Healthcare (MOH)85✓ Walgreens Boots Alliance, Inc. (WBA)86✓ Allstate Corporation (ALL)87✓ Progressive Corporation (PGR)88— Prudential Financial, Inc. (PRU)89 McKesson Corp (MCK)

Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Humana.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1UnitedHealth Group Inc.2025Stephen Hemsley$596,154$0$60,000,024$0$60,938,062
2HCA Healthcare, Inc.2025Samuel Hazen1,577,8158,474,5438,514,0905,416,73226,456,606
3Aflac, Inc.2025Daniel Amos1,441,10011,340,78206,350,19325,033,687
4McKesson Corp2026Brian Tyler1,591,66717,201,20204,456,66824,213,044
5Allstate Corporation2025Thomas Wilson1,465,38510,886,4004,530,2275,597,23522,920,898
6The Cigna Group2025David Cordani1,600,00013,929,1613,400,0193,200,00022,866,134
7Elevance Health, Inc.2025Gail Boudreaux1,600,00013,440,2774,199,7652,768,00022,582,314
8Cardinal Health, Inc.2026Jason Hollar1,500,00016,259,91804,278,75022,574,349
9MetLife, Inc.2025Michel Khalaf1,500,00014,797,60104,600,00022,364,273
10CVS Health Corp2025J. David Joyner1,500,00014,499,93104,695,90021,214,084
11Centene Corporation2025Sarah London1,473,07715,537,73302,109,44619,506,298
12Humana2025James Rechtin1,348,55813,868,14103,034,74018,757,075
13Molina Healthcare2025Joseph Zubretsky1,600,00016,199,9880018,340,783
14Cencora2025Robert Mauch1,350,00012,000,21804,283,21318,256,227
15DaVita Inc.2025Javier Rodriguez1,500,00011,442,4812,699,9822,089,49118,210,597
16Progressive Corporation2025Susan Patricia Griffith1,094,23111,000,278—5,443,79917,705,924
17Walgreens Boots Alliance, Inc.2024Timothy Wentworth1,290,38511,600,7440013,282,800
18Prudential Financial, Inc.2025Andrew Sullivan1,089,2054,618,26604,664,00011,408,423

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Humana112%PSU 60 · RSU 40Yes — Relative TSRFarient Advisors, LLC
Aflac, Inc.not disclosedPSU 100NoMercer (US) LLC
Allstate Corporation127.2%PSA 70 · Option 30Yes — Relative Total Shareholder Return (TSR)Pay Governance
Cardinal Health, Inc.not disclosedPSU 60 · RSU 40Yes — Relative TSR modifierKorn Ferry
Cencora181.3%PSU 60 · RSU 40Yes — Relative TSRPearl Meyer & Partners
Centene Corporation71.6%PSU 60 · RSU 40Yes — Relative TSRFW Cook
CVS Health Corp156.5%PSU 60 · RSU 20 · Options 20Yes — rTSR ModifierKorn Ferry
DaVita Inc.93%PSU 60 · RSU 20 · Options 20Yes — Relative TSR v. S&P Health Care Services Select Industry IndexCompensia
Elevance Health, Inc.86.5%PSU 52 · RSU 24 · Options 24NoWillis Towers Watson (WTW)
HCA Healthcare, Inc.195.78%SAR 50 · PSU 50NoSemler Brossy
McKesson Corp140%PSU 60 · RSU 40Yes — Total Shareholder Return (TSR) relative to comparator groupKorn Ferry
MetLife, Inc.100.5%PSU 70 · RSU 30Yes — TSR relative to TSR Peer GroupMeridian Compensation Partners, LLC
Molina Healthcarenot disclosedPSU 60 · RSU 40NoFW Cook
Progressive Corporation199%PSU 82 · RSU 18NoSemler Brossy
Prudential Financial, Inc.106%PSU 75 · RSU 25NoFW Cook
The Cigna Group100%PSU 60 · RSU 20 · Options 20NoPay Governance
UnitedHealth Group Inc.not disclosedPSU 50 · Options 25 · RSU 25NoPay Governance
Walgreens Boots Alliance, Inc.not disclosedRSU 100not disclosedMercer

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-04-1697,237,8514,669,732295,14595.42%Passed
20252025-04-1789,310,63110,567,799131,53889.42%Passed
20242024-04-1889,131,1428,422,934253,87391.13%Passed
20232023-04-2099,607,3209,492,897297,37491.05%Passed
20222022-04-21103,820,9705,600,956158,01894.74%Passed
20212021-04-22105,291,5895,861,600205,92194.55%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-04-1695.42%a
20252025-04-1789.42%b
20242024-04-1891.13%c

a. Approved under the standard stated in the filing — “Proposal Three • 2026 Proxy Statement | Humana 83 TABLE OF CONTENTS Vote Required and Recommendation of the Board of Directors This proposal requires the affirmative vote of the holders of a majority of the votes cast affirmatively or negatively on this proposal for the approval of the non-binding advisory vote with respect to the compensation of the Company's Named Executive Officers.”.

b. Approved under the standard stated in the filing — “Abstentions, Shares not present at the meeting and broker non-votes have no effect on the approval of this non-binding advisory vote.”.

c. Approved under the standard stated in the filing — “Abstentions, Shares not present at the meeting and broker non-votes will have the same effect as a vote against this proposal.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)226 : 1
CEO total compensation$18,757,075
Median employee compensation$82,935
Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Kurt J. HilzingerDirector2026-03-31A536$171$91,474Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-03-31—25—~4,3351 insider, 1 accrual row
Sanjay ShettyPresident, CenterWell2026-04-01A88700CommonForm 4 ↗
Sanjay ShettyPresident, CenterWell2026-04-01D40117570,351CommonForm 4 ↗
Michelle O'HaraChief Human Resources Officer2026-05-01A10,48500CommonForm 4 ↗
Celeste MelletChief Financial Officer2026-05-01D15,38700CommonForm 4 ↗
Sanjay ShettyPresident, CenterWell2026-05-01A9,94500CommonForm 4 ↗
James A. RechtinPresident & CEO2026-05-01A35,63300CommonForm 4 ↗
Aaron MartinPresident, Medicare Advantage2026-05-01A8,20600CommonForm 4 ↗
Joseph C. VenturaChief Legal Officer2026-05-01A10,31800CommonForm 4 ↗
David DintenfassPresident, Enterprise Growth2026-05-01A11,27300CommonForm 4 ↗
Japan MehtaChief Information Officer2026-05-01A9,44800CommonForm 4 ↗
Robert Stuart FieldDirector2026-05-01A85200CommonForm 4 ↗
Kurt J. HilzingerDirector2026-06-30A23339291,411Derivative, Class A CommonForm 4 ↗
Frederick John CrawfordDirector2026-08-01A54400CommonForm 4 ↗
Paul John SmithDirector2026-08-01A54400CommonForm 4 ↗
Shantanu NundyChief Medical Officer2026-09-01A2,54900CommonForm 4 ↗
Kurt J. HilzingerDirector2026-09-30A23838591,609Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 18 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Kurt J. HilzingerDirector2026-03-31A536$171$91,474Derivative, Class A CommonForm 4 ↗
George Renaudin IIPresident, Insurance2026-03-31A251734,335Derivative, Class A CommonForm 4 ↗
Sanjay ShettyPresident, CenterWell2026-04-01A88700CommonForm 4 ↗
Sanjay ShettyPresident, CenterWell2026-04-01D40117570,351CommonForm 4 ↗
Michelle O'HaraChief Human Resources Officer2026-05-01A10,48500CommonForm 4 ↗
Celeste MelletChief Financial Officer2026-05-01D15,38700CommonForm 4 ↗
Sanjay ShettyPresident, CenterWell2026-05-01A9,94500CommonForm 4 ↗
James A. RechtinPresident & CEO2026-05-01A35,63300CommonForm 4 ↗
Aaron MartinPresident, Medicare Advantage2026-05-01A8,20600CommonForm 4 ↗
Joseph C. VenturaChief Legal Officer2026-05-01A10,31800CommonForm 4 ↗
David DintenfassPresident, Enterprise Growth2026-05-01A11,27300CommonForm 4 ↗
Japan MehtaChief Information Officer2026-05-01A9,44800CommonForm 4 ↗
Robert Stuart FieldDirector2026-05-01A85200CommonForm 4 ↗
Kurt J. HilzingerDirector2026-06-30A23339291,411Derivative, Class A CommonForm 4 ↗
Frederick John CrawfordDirector2026-08-01A54400CommonForm 4 ↗
Paul John SmithDirector2026-08-01A54400CommonForm 4 ↗
Shantanu NundyChief Medical Officer2026-09-01A2,54900CommonForm 4 ↗
Kurt J. HilzingerDirector2026-09-30A23838591,609Derivative, Class A CommonForm 4 ↗
Sources (89 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Celeste Mellet. DEF 14A, filed 2026-03-06. Section “Summary Compensation Table”. As printed: 18,922,704. View filing ↗
  • Section 01, James Rechtin. DEFR 14A, filed 2026-03-06. Section “Summary Compensation Table” · page 62. As printed: 18,757,075. View filing ↗
  • Section 01, Japan Mehta. DEF 14A, filed 2026-03-06. Section “Summary Compensation Table”. As printed: 9,564,563. View filing ↗
  • Section 01, Michelle O'Hara. DEF 14A, filed 2026-03-06. Section “Summary Compensation Table”. As printed: 8,942,638. View filing ↗
  • Section 01, Sanjay Shetty. DEF 14A, filed 2026-03-06. Section “Summary Compensation Table”. As printed: 7,155,679. View filing ↗
  • Section 01, Susan Diamond. DEF 14A, filed 2026-03-06. Section “Summary Compensation Table”. As printed: 2,382,930. View filing ↗
  • Section 03, Japan Mehta PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Sanjay Shetty PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Celeste Mellet RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Sanjay Shetty PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Celeste Mellet RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Michelle O'Hara . DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Japan Mehta RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Sanjay Shetty RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, James Rechtin RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Celeste Mellet PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Michelle O'Hara PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Michelle O'Hara EQUITY. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, Japan Mehta RSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 03, James Rechtin PSU. DEF 14A. Section “COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-03-06. Section “CEO Pay Ratio”. As printed: 226 : 1. View filing ↗
  • Section 08, Kurt J. Hilzinger. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 610,078. View filing ↗
  • Section 08, Karen W. Katz. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 385,578. View filing ↗
  • Section 08, Wayne A. I. Frederick, M.D. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 385,506. View filing ↗
  • Section 08, Marcy S. Klevorn. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 382,378. View filing ↗
  • Section 08, Jorge S. Mesquita. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 366,084. View filing ↗
  • Section 08, Frank A. D'Amelio. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 352,878. View filing ↗
  • Section 08, Raquel C. Bono, M.D. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 352,378. View filing ↗
  • Section 08, David T. Feinberg, M.D. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 341,280. View filing ↗
  • Section 08, John W. Garratt. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 340,866. View filing ↗
  • Section 08, Gordon Smith. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 325,092. View filing ↗
  • Section 08, Brad D. Smith. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 108,760. View filing ↗
  • Section 08, James A. Rechtin. DEF 14A, filed 2026-03-06. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 02, Kurt J. Hilzinger 2026-03-31. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, George Renaudin II 2026-03-31. Form 4, filed 2026-04-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sanjay Shetty 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sanjay Shetty 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Michelle O'Hara 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Celeste Mellet 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sanjay Shetty 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, James A. Rechtin 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Aaron Martin 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Joseph C. Ventura 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, David Dintenfass 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Japan Mehta 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Robert Stuart Field 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kurt J. Hilzinger 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Frederick John Crawford 2026-08-01. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Paul John Smith 2026-08-01. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Shantanu Nundy 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kurt J. Hilzinger 2026-09-30. Form 4, filed 2026-10-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-04-20. Item 5.07 · say-on-pay result. As reported: 95.42% (votes for as printed: 97,237,851). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-04-18. Item 5.07 · say-on-pay result. As reported: 89.42% (votes for as printed: 89,310,631). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-04-19. Item 5.07 · say-on-pay result. As reported: 91.13% (votes for as printed: 89,131,142). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 1,641,667 + equity 2,067,617 + all other 241,594 = 3,950,878, summed across the director compensation table rows.
  • UnitedHealth Group Inc., Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group Inc.'s own proxy. As printed: 60,938,062. View filing ↗
  • HCA Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. View filing ↗
  • Aflac, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Aflac, Inc.'s own proxy. As printed: 25,033,687. View filing ↗
  • McKesson Corp, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corp's own proxy. As printed: 24,213,044. View filing ↗
  • Allstate Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Allstate Corporation's own proxy. As printed: 22,920,898. View filing ↗
  • The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
  • Elevance Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. View filing ↗
  • Cardinal Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health, Inc.'s own proxy. As printed: 22,574,349. View filing ↗
  • MetLife, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in MetLife, Inc.'s own proxy. As printed: 22,364,273. View filing ↗
  • CVS Health Corp, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corp's own proxy. As printed: 21,214,084. View filing ↗
  • Centene Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Centene Corporation's own proxy. As printed: 19,506,298. View filing ↗
  • Humana (subject), Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana's own proxy. As printed: 18,757,075. View filing ↗
  • Molina Healthcare, Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Molina Healthcare's own proxy. As printed: 18,340,783. View filing ↗
  • Cencora, Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora's own proxy. As printed: 18,256,227. View filing ↗
  • DaVita Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. View filing ↗
  • Progressive Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Progressive Corporation's own proxy. As printed: 17,705,924. View filing ↗
  • Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
  • Prudential Financial, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Prudential Financial, Inc.'s own proxy. As printed: 11,408,423. View filing ↗
  • Section 10a, HCA Healthcare, Inc. reciprocity. DEF 14A. HCA Healthcare, Inc. names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Aflac, Inc. reciprocity. DEF 14A. Aflac, Inc. names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Centene Corporation reciprocity. DEF 14A. Centene Corporation names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Elevance Health, Inc. reciprocity. DEF 14A. Elevance Health, Inc. names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, UnitedHealth Group Inc. reciprocity. DEF 14A. UnitedHealth Group Inc. names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Cencora reciprocity. DEF 14A. Cencora names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, DaVita Inc. reciprocity. DEF 14A. DaVita Inc.'s most recent proxy was read; its disclosed peer group does not include Humana. View filing ↗
  • Section 10a, Cardinal Health, Inc. reciprocity. DEF 14A. Cardinal Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Humana. View filing ↗
  • Section 10a, Molina Healthcare reciprocity. DEF 14A. Molina Healthcare names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc. names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Allstate Corporation reciprocity. DEF 14A. Allstate Corporation names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Progressive Corporation reciprocity. DEF 14A. Progressive Corporation names Humana in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Prudential Financial, Inc. reciprocity. DEF 14A. Prudential Financial, Inc.'s most recent proxy was read; its disclosed peer group does not include Humana. View filing ↗
Get the full report — $500